Why the study?
Does Controlled-Release Metoprolol improve Total Mortality, Hospitalizations, and Well-being in Patients with Heart Failure?
Does Controlled-Release Metoprolol improve Total Mortality, Hospitalizations, and Well-being in Patients with Heart Failure?
Supports adding controlled-release metoprolol to HF therapy; confirms mortality benefit and extends to hospitalizations plus well-being.
HJALMARSON, AKE; FAGERBERG, SIDNEY GOLDSTEIN BJÖRN; WREDEL, HANS; WAAGSTEIN, FINN; KJEKSHUS, JOHN; WIKSTRAND, JOHN; EL ALLAF, DIA; VÍTOVEC, JIRÍ; ALDERSHIVILE, JAN; HALINEN, MATTI; DIETZ, RAINER; NEUHAUS, KARL-LUDWIG; JÁNOSI, ANDRÁS; THORGEIRSSON, GUDMUNDUR; DUNSELMAN, PETER H.J.M.; GULLESTAD, LARS; KUCH, JERZY; HERLITZ, JOHAN; RICKENBACHER, PETER; BALL, STEPHEN; GOTTLIEB, STEPHEN PRAKASH DEEDWANIA FOR THE MERIT-HF STUDY GROUP Author Information
No takes yet. Share an insight, caveat, or question.
Hjalmarson et al. (2000) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: